Showing results (311-320 of 325) with videos related to
Sort By:
Pageof 33
European Urology Open Science|September 12, 2024
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter CohortGiancarlo Marra, Federico Lesma, Gabriele Montefusco, et al.The Journal of Urology|February 10, 2025
Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter StudyGiancarlo Marra, Francesco Barletta, Simone Scuderi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.Clinical Genitourinary Cancer|December 28, 2023
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter StudyGiancarlo Marra, Pawel Rajwa, Claudia Filippini, et al.American Journal of Human Genetics|December 4, 2012
Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis-intellectual-disability syndromeLina Basel-Vanagaite, Bruno Dallapiccola, Ramiro Ramirez-Solis, et al.Nature Genetics|September 29, 2014
Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid featuresDavor Lessel, Bruno Vaz, Swagata Halder, et al.The Journal of Clinical Investigation|October 26, 2018
DNA hypermethylation within TERT promoter upregulates TERT expression in cancerDonghyun D Lee, Ricardo Leão, Martin Komosa, et al.World Journal of Urology|September 19, 2024
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic reviewErnest Kaufmann, Stefanie Aeppli, Winfried Arnold, et al.BJU International|February 16, 2026
Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancerMulham Al-Nader, Claudia Kesch, Osama Mahmoud, et al.Prostate Cancer and Prostatic Diseases|January 5, 2024
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Lieke Wever, Timo F W Soeterik, et al.Pageof 33